ASBP
Aspire Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.87
−4.11%Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.00
- EPS estimate
- —
- Revenue actual
- $63.1K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 13, 2026